CVS Health has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program.
Retail expansion follows successful vaccination effort at long-term care facilities
WOONSOCKET, R.I., March 11, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program (FRPP). The company is now administering vaccines in nearly 1,200 stores across 29 states and Puerto Rico (states and jurisdictions activated within the past week in bold):
Alabama, Arizona, California, Colorado, Connecticut, Florida, Hawaii, Illinois, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nevada, New Jersey, New York (now including New York City), Ohio, Oklahoma, Pennsylvania (now including Philadelphia), Puerto Rico, Rhode Island, South Carolina, Texas, Utah, Vermont, and Virginia.
“We’re increasing the number of active stores and expanding to additional states as fast as supply allows, with the capacity to administer 20 – 25 million shots per month,” said Karen S. Lynch, President and Chief Executive Officer, CVS Health. “We’re also focused on priority populations, including vulnerable communities disproportionately impacted by the pandemic as well as teachers and school support staff.”
On March 2 the Biden Administration announced that for the month of March, FRPP participants would prioritize vaccinating pre-K through 12 educators and staff and child care workers. From March 3 to March 10, this population accounted for more than 30 percent of COVID-19 vaccine appointments at CVS Pharmacy locations.
Appointments in the newly activated states and jurisdictions will start to become available for booking on Saturday, March 13. Vaccines in a retail setting are offered on an appointment-only basis via CVS.com or through the CVS Pharmacy app, and those without online access can contact customer service: (800) 746-7287.
Long-term care vaccination effort a success
Since CVS Health began administering COVID-19 vaccine doses to residents and staff at over 40,000 long-term care facilities across the country in late December, there has been a dramatic drop in COVID-19 cases and deaths. In fact, according to Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services data, between December 20 and February 21 there has been a 94 percent decrease in COVID-19 cases, and an 84 percent decrease in COVID-19 deaths.
Per the company’s publicly available data, CVS Pharmacy teams have completed second doses at all skilled nursing facilities, and third and final visits are 90 percent complete. Second doses at assisted living and other facilities are 91 percent complete, with more than half of third and final visits complete.1 CVS Health has administered nearly 4.5 million COVID-19 vaccine doses through the Pharmacy Partnership for Long-Term Care Program.
Multimedia assets, including b-roll and still photography from long-term care facility and in-store COVID-19 vaccinations, are available here. More information on steps CVS Health has taken to address the pandemic is available at the company’s frequently updated COVID-19 resource center.
About CVS Health
CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB® locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we’re transforming health at www.cvshealth.com.
Cautionary Statement Concerning Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to risks and uncertainties described in our Securities and Exchange Commission (“SEC”) filings, including those set forth in the Risk Factors section and under the heading “Cautionary Statement Concerning Forward Looking Statements” in our most recently filed Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020. You are cautioned not to place undue reliance on CVS Health’s forward looking statements. CVS Health’s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.
Media contact
T.J. Crawford
212-457-0583
crawfordt2@aetna.com
1 Excludes facilities that 1) requested a later date due to a COVID-19 outbreak or other reason, 2) were rescheduled due to lack of responsiveness, or 3) requested to be added to the program after the start date or did not meet original program criteria regarding distance from CVS Pharmacy locations, but CVS Health has opted to support.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cvs-health-now-offering-covid-19-vaccines-in-29-states-301245080.html
SOURCE CVS Health
Company Codes: NYSE:CVS
